MedTrace Logo

The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function

NCT04043026 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 56

Last updated 2022-08-08

No results posted yet for this study

Summary

This study is designed to investigate the role of lipids/lipoproteins as a potential cause for the harmful changes seen in fibrin clot properties with renal dysfunction and atrial fibrillation

Conditions

Interventions

DRUG

Statin

Any statin therapy

Sponsors & Collaborators

  • Liverpool Centre for Cardiovascular Science

    collaborator UNKNOWN

  • Liverpool Heart and Chest Hospital NHS Foundation Trust

    collaborator OTHER

  • Liverpool John Moores University

    collaborator OTHER

  • University of Leeds

    collaborator OTHER

  • University of Liverpool

    lead OTHER

Principal Investigators

  • Wern Yew Ding · University of Liverpool

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-26
Primary Completion
2022-08-01
Completion
2022-08-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04043026 on ClinicalTrials.gov